BMRN vs PMI · P/E 40, rev $1.76B vs rev $4.9M
Biomarin Pharmaceutical Inc (BMRN) versus Picard Medical, Inc. (PMI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Picard Medical, Inc. (PMI) is a medical devices company listed on AMEX.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PMI revenue for 2025-12-31 was $4.9M. Net income was -$27.0M. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. PMI currently screens at market cap $16.9M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PMI currently screens at market cap $16.9M.
Not investment advice. Open the BMRN and PMI stock pages for the full models.
Not investment advice.